NRGEX | RYWCX | NRGEX / RYWCX | |
Total Expense Ratio | 0.03 | 2.29 | 1% |
Annual Report Gross Expense Ratio | 0.69 | 2.34 | 29% |
Fund Existence | 4 years | 22 years | - |
Gain YTD | -3.342 | 7.704 | -43% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.71B | 4.7M | 185,483% |
Annual Yield % from dividends | 0.54 | 0.03 | 1,757% |
Returns for 1 year | -9.46 | -9.48 | 100% |
Returns for 3 years | 8.17 | 19.79 | 41% |
Returns for 5 years | N/A | -27.34 | - |
Returns for 10 years | N/A | -20.74 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNIX | 75.85 | 0.47 | +0.62% |
Janus Henderson Global Life Sciences I | |||
TICSX | 7.39 | 0.04 | +0.54% |
Touchstone Small Company Instl | |||
GSVPX | 16.76 | 0.05 | +0.30% |
Goldman Sachs Small/Mid Cap Equity P | |||
RLBBX | 38.66 | 0.03 | +0.08% |
American Funds American Balanced R2 | |||
SGQCX | 42.96 | -0.03 | -0.07% |
DWS International Growth C |